| P50 | author | Konkal-Matt R Prasad | Q63230211 |
| | Brent A French | Q57233642 |
| P2093 | author name string | John M Sanders | |
| | Brian H Annex | |
| | R John Lye | |
| | Amina Saqib | |
| | Arabindra B Katwal | |
| P2860 | cites work | Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model | Q64376794 |
| | AAV-mediated VEGF gene transfer into skeletal muscle stimulates angiogenesis and improves blood flow in a rat hindlimb ischemia model | Q64378972 |
| | Epidemiology of peripheral arterial disease | Q71631578 |
| | Peripheral arterial disease | Q77053565 |
| | Genetic background influences therapeutic effectiveness of VEGF | Q79085598 |
| | Essential role of extracellular SOD in reparative neovascularization induced by hindlimb ischemia | Q80547915 |
| | Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal | Q82991530 |
| | Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy | Q24535690 |
| | Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1 | Q28141355 |
| | VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses | Q28201087 |
| | Mechanisms of angiogenesis and arteriogenesis | Q29617257 |
| | Adeno-associated virus vector mediated gene transfer to pancreatic beta cells | Q30306214 |
| | Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution | Q30431585 |
| | Topoisomerase inhibition accelerates gene expression after adeno-associated virus-mediated gene transfer to the mammalian heart | Q30442929 |
| | The effect of the controlled release of basic fibroblast growth factor from ionic gelatin-based hydrogels on angiogenesis in a murine critical limb ischemic model | Q33275386 |
| | Asialoerythropoietin is a strong modulator of angiogenesis by bone-marrow cells | Q33311719 |
| | cGMP-dependent protein kinase I is crucial for angiogenesis and postnatal vasculogenesis | Q33418301 |
| | Extracellular SOD-derived H2O2 promotes VEGF signaling in caveolae/lipid rafts and post-ischemic angiogenesis in mice | Q33565541 |
| | A quantitative trait locus (LSq-1) on mouse chromosome 7 is linked to the absence of tissue loss after surgical hindlimb ischemia | Q33895724 |
| | Clades of Adeno-associated viruses are widely disseminated in human tissues. | Q34193756 |
| | Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb - on the way to the clinic | Q34319721 |
| | Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors | Q34998573 |
| | Therapeutic angiogenesis for peripheral artery disease: cytokine therapy | Q37115688 |
| | Clinical gene therapy using recombinant adeno-associated virus vectors | Q37140649 |
| | Human studies of angiogenic gene therapy | Q37406656 |
| | A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway | Q39420491 |
| | Muscle-specific overexpression of the adenovirus primary receptor CAR overcomes low efficiency of gene transfer to mature skeletal muscle | Q39602470 |
| | Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 |
| | Sustained release of erythropoietin using biodegradable gelatin hydrogel microspheres persistently improves lower leg ischemia. | Q44520062 |
| | Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice | Q44559348 |
| | Adeno-associated virus vectors simultaneously encoding VEGF and angiopoietin-1 enhances neovascularization in ischemic rabbit hind-limbs | Q45406014 |
| | Adeno-associated viral vector-mediated gene transfer of VEGF normalizes skeletal muscle oxygen tension and induces arteriogenesis in ischemic rat hindlimb | Q45858511 |
| | Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure. | Q45878067 |
| | Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion | Q45880288 |
| | Inflammatory damage following first-generation replication-defective adenovirus controlled by anti-LFA-1. | Q45881314 |
| | Gene transfer of extracellular superoxide dismutase protects against vascular dysfunction with aging | Q46916981 |
| | An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia. | Q51186989 |
| | Engineered zinc finger-activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hindlimb ischemia. | Q51600740 |
| P433 | issue | 3 | |
| P921 | main subject | overexpression | Q61643320 |
| P304 | page(s) | 810-818 | |
| P577 | publication date | 2011-07-02 | |
| P1433 | published in | Journal of Vascular Surgery | Q15755733 |
| P1476 | title | Adeno-associated virus serotype 9-mediated overexpression of extracellular superoxide dismutase improves recovery from surgical hind-limb ischemia in BALB/c mice | |
| P478 | volume | 54 | |